| Literature DB >> 12603236 |
Erkki Vuori1, John A Henry, Ilkka Ojanperä, Raija Nieminen, Taru Savolainen, Pia Wahlsten, Matti Jäntti.
Abstract
Four deaths following the ingestion of moclobemide and MDMA ('ecstasy') are described. The probable cause of death in each case was serotonin syndrome as a result of an interaction between the two drugs. As none of the victims had been prescribed moclobemide it seems that each had taken the drug to enhance the effects of MDMA, with fatal consequences. Warnings are needed against misinformed attempts to potentiate the pharmacological effects of illicit drugs.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12603236 DOI： 10.1046/j.1360-0443.2003.00292.x
Source DB: PubMed Journal: Addiction ISSN： 0965-2140 Impact factor: 6.526